China's Pharmaceuticals Market Analysis And After Accession To Wto Countermeasures

Pharmaceutical industry is widely regarded as the most prosperous hi-tech industry and one of the most fast-growing five industries in terms of international trade. International pharmaceutical markets are highly competitive with focus on new technologies. Based on the competitive trend in the international medicine market, the big pharmaceutical companies in the world are currently laying down their global marketing strategies for the next century. China is going to enter WTO in the near future. This paper discusses how Chinese pharmaceutical industry meet the challenges brought about by entering WTO.In this paper, SWOT analysis for pharmaceutical industry is discussed in 2 chapters. Chapter 1, after a brief classification of medicines, focuses on a detailed analyzes of the consumption volumes of prescription medicines and OTC medicines on the bases of statistic data of sales volume in domestic and overseas medicine markets. This part, then, goes on with its further discussion of, according to the results of marketing research of medicine wholesale companies, different medicines are sequenced in accordance with their sales figures. Also discussed are the characteristics of imported medicines market, the structure of imported medicines and their market shares. The same analyses are made on medicines produced by joint ventures and new medicines, too. Last, but not the least, this part takes into account for discussion the market shares of different medicines and the six corresponding trends Chinese medicine development of, on the basis of market dynamic data analysis of retail medicines. Chapter 2 deals with industry environment, and the opportunities and threats faced by pharmaceutical companies in our country. Also discussed in this part are the abilities of existence and core competencies of pharmaceutical companies in our country.According to the analyses of market, industry and industry environment in the previous chapters together with the entering of WTO, the macro and micro strategies are proposed to meet the challenges brought about by entering WTO. These strategies provide the guidance for practice. Especially the idea of creating National Medicine Group not only complies with the goals of both national pharmaceutical industry and the reform of state-owned enterprises, but also meets the need to compete against international pharmaceutical companies after China's entering of WTO. This is what really makes this paper to be sort of being original.